Literature DB >> 7076292

Protection of mice from infection with Streptococcus pneumoniae by anti-phosphocholine antibody.

J Yother, C Forman, B M Gray, D E Briles.   

Abstract

Anti-phosphocholine (PC) antibody mediated protection against many strains of Streptococcus pneumoniae, and hybridoma anti-PC antibodies protected mice from fatal infections with types 1 and 3 S. pneumoniae. Live types 1, 3, 5, 6A, and 19F S. pneumoniae had similar amounts of surface PC accessible to antibody. Furthermore, mice expressing the X-linked immunodeficiency (xid) of the CBA/N strain were found to be more susceptible to infection with S. pneumoniae of types 3, 6A, and 19F than were immunologically normal mice. The only exception to these results was with the type 5 strain, which was highly virulent for both xid and normal mice. In addition, we were unable to protect mice against infection with the type 5 strain by using anti-PC antibody.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7076292      PMCID: PMC351201          DOI: 10.1128/iai.36.1.184-188.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  11 in total

1.  Biological properties of an immunogenic pneumococcal subcellular preparation.

Authors:  H C Thompson; T K Eisenstein
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

2.  Mouse Igg3 antibodies are highly protective against infection with Streptococcus pneumoniae.

Authors:  D E Briles; J L Claflin; K Schroer; C Forman
Journal:  Nature       Date:  1981-11-05       Impact factor: 49.962

3.  A simplification of the radioactive antigen-binding test by a double label technique.

Authors:  E C Gotschlich
Journal:  J Immunol       Date:  1971-09       Impact factor: 5.422

4.  Immune response deficiency of BSVS mice. II. Generalized deficiency to thymus-dependent antigens.

Authors:  D E Briles; R M Perlmutter; D Hansburg; J R Little; J M Davie
Journal:  Eur J Immunol       Date:  1979-04       Impact factor: 5.532

5.  Phagocytosis and killing of salmonella typhimurium by peritoneal exudate cells.

Authors:  D E Briles; J Lehmeyer; C Forman
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

6.  Pneumococcal Forssman antigen. A choline-containing lipoteichoic acid.

Authors:  E B Briles; A Tomasz
Journal:  J Biol Chem       Date:  1973-09-25       Impact factor: 5.157

7.  Nature of the cross-protective antigen in subcellular vaccines of Streptococcus pneumoniae.

Authors:  C C Au; T K Eisenstein
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

8.  Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae.

Authors:  D E Briles; M Nahm; K Schroer; J Davie; P Baker; J Kearney; R Barletta
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

9.  Pneumococcal C-substance, a ribitol teichoic acid containing choline phosphate.

Authors:  D E Brundish; J Baddiley
Journal:  Biochem J       Date:  1968-12       Impact factor: 3.857

10.  Anti-phosphocholine hybridoma antibodies. I. Direct evidence for three distinct families of antibodies in the murine response.

Authors:  J L Claflin; S Hudak; A Maddalena
Journal:  J Exp Med       Date:  1981-02-01       Impact factor: 14.307

View more
  48 in total

1.  Genetic alteration of capsule type but not PspA type affects accessibility of surface-bound complement and surface antigens of Streptococcus pneumoniae.

Authors:  Melanie Abeyta; Gail G Hardy; Janet Yother
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

2.  Pneumococcal antigens and serum antibody responses in experimentally induced sinusitis.

Authors:  K M Westrin; A Freijd; P Stierna
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

3.  Rabbit antibodies to the cell wall polysaccharide of Streptococcus pneumoniae fail to protect mice from lethal challenge with encapsulated pneumococci.

Authors:  S C Szu; R Schneerson; J B Robbins
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

4.  Long-term Immunotoxic Effects of Oral Prenatal and Neonatal Atrazine Exposure.

Authors:  Ida Holásková; Meenal Elliott; Kathleen Brundage; Ewa Lukomska; Rosana Schafer; John B Barnett
Journal:  Toxicol Sci       Date:  2019-04-01       Impact factor: 4.849

5.  Protective immunity against Salmonella typhimurium elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly(DL-lactide-co-glycolide) microspheres.

Authors:  K Allaoui-Attarki; S Pecquet; E Fattal; S Trollé; E Chachaty; P Couvreur; A Andremont
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

6.  Determination of antibodies to pneumococcal C polysaccharide in patients with community-acquired pneumonia.

Authors:  H Holmberg; A Krook; A M Sjögren
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

7.  Antipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens.

Authors:  D E Briles; C Forman; J C Horowitz; J E Volanakis; W H Benjamin; L S McDaniel; J Eldridge; J Brooks
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

8.  A modified surface killing assay (MSKA) as a functional in vitro assay for identifying protective antibodies against pneumococcal surface protein A (PspA).

Authors:  Kristopher R Genschmer; Mary Ann Accavitti-Loper; David E Briles
Journal:  Vaccine       Date:  2013-11-06       Impact factor: 3.641

9.  Correlation of serum opsonins with in vitro phagocytosis of Streptococcus pneumoniae.

Authors:  D S Chudwin; S G Artrip; A Korenblit; G Schiffman; S Rao
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

Review 10.  Animal models of Streptococcus pneumoniae disease.

Authors:  Damiana Chiavolini; Gianni Pozzi; Susanna Ricci
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.